FDA Inspection 1018102 — University of Louisville Physicians OBGYN & Womens Health Fertility Center

University of Louisville Physicians OBGYN & Womens Health Fertility Center — FEI 3004557180

The FDA completed an inspection of University of Louisville Physicians OBGYN & Womens Health Fertility Center on July 14, 2017 in Louisville, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Louisville, KY (United States)

Citations

IDCFRDescription
1223021 CFR 1271.50(a)Responsible person to determine, document
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1249621 CFR 1271.85(b)(2)SOP for release; reactive for CMV